If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Imaging Biometrics Adds to Development Team

27 Jan 2020 09:29

RNS Number : 9880A
IQ-AI Limited
27 January 2020
 

IQ-AI Ltd

("IQ-AI" or the "Company")

 

IQ-AI's Subsidiary Imaging Biometrics Adds to Development Team

 

IQ-AI is pleased to announce its subsidiary, Imaging Biometrics, LLC (IB), has enlisted the services of Jay Urbain, PhD to its software development team. Dr. Urbain brings significant experience in machine learning, deep learning, and data science, with significant contributions across multiple industrial applications including healthcare.

 

Dr. Urbain started his career at Marquette Medical Systems (now part of GE Healthcare) and for the past 16 years held the position of professor at the Milwaukee School of Engineering where he developed and taught courses in artificial intelligence and general computer science topics. As an nVidia Certified Deep Learning Instructor, Dr. Urbain conducts deep learning workshops in collaboration with nVidia and his research passion is at the intersection of machine learning and healthcare. He remains an adjunct professor at the Milwaukee School of Engineering as well as at the Medical College of Wisconsin.

 

Michael Schmainda, non-executive director of IQ-AI, said, "We are very excited that Dr. Urbain has joined IB's development team. His background and expertise dovetail perfectly with IB's existing team of software engineers, and will catalyze the development of new technologies and products".

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

-ENDS-

 

For further information, please contact:

IQ-AI Limited

Trevor Brown/Vinod Kaushal/Qu Li

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

About IQ-AI Ltd 

IQ-AI, Ltd, the parent company of StoneChecker® and Imaging Biometrics®, is focused on advanced and state of the art medical software and services. (IQ-AI.ltd). Imaging Biometrics develops and provides visualization and analytical solutions that enable clinicians to better diagnose and treat diseases with greater confidence. Through close collaboration with researchers and clinicians, sophisticated advancements are translated into platform-independent software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualization software seamlessly integrates into routine workflows. Please visit www.imagingbiometrics.com for further information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRGCGDBUDDDGGR
Date   Source Headline
31st Jul 20097:00 amRNSHalf Yearly Report
7th May 20092:23 pmRNSDirectorate Change
27th Apr 20097:00 amRNSDirector/PDMR Shareholding
22nd Apr 200910:01 amRNSAGM & Interim Management Statement
16th Apr 20099:55 amRNSDirector/PDMR Shareholding
30th Mar 20096:29 pmRNSBlocklisting Interim Review
13th Mar 20097:00 amRNSFinal Results
18th Feb 20097:00 amRNSDirectorate Change
21st Jan 20097:00 amRNSTrading Statement
10th Dec 200810:00 amRNSDirector/PDMR Shareholding
21st Nov 20087:10 amRNSOffer Talks Terminated
21st Nov 20087:00 amRNSStatement re Possible Offer
18th Nov 20088:28 amRNSEPT Disclosure
12th Nov 200810:24 amRNSEPT Disclosure with Trade Amendment
11th Nov 20088:40 amRNSEPT Disclosure
6th Nov 20088:46 amRNSEPT Disclosure
5th Nov 20089:09 amRNSEPT Disclosure
3rd Nov 20089:12 amRNSEPT Disclosure
31st Oct 20089:47 amRNSEPT Disclosure
29th Oct 20088:45 amRNSEPT Disclosure
28th Oct 20089:38 amRNSEPT Disclosure
27th Oct 20082:14 pmRNSEPT Disclosure - Replacement
27th Oct 200810:38 amRNSEPT Disclosure
24th Oct 20089:23 amRNSEPT Disclosure
23rd Oct 20089:35 amRNSEPT Disclosure
21st Oct 20082:11 pmRNSInterim Management Statement
17th Oct 20089:24 amRNSEPT Disclosure
14th Oct 200811:36 amRNSEPT Disclosure
14th Oct 20089:31 amRNSEPT Disclosure
10th Oct 20089:44 amRNSEPT Disclosure
9th Oct 20089:26 amRNSEPT Disclosure
8th Oct 20088:53 amRNSEPT Disclosure
6th Oct 200810:48 amRNSEPT Disclosure
3rd Oct 20089:14 amBUSRule 8.3 - Flying Brands
1st Oct 20088:31 amRNSEPT Disclosure
30th Sep 20089:00 amRNSBlocklisting Interim Review
25th Sep 20088:42 amRNSEPT Disclosure
24th Sep 200810:47 amRNSEPT Disclosure
16th Sep 20088:32 amRNSEPT Disclosure
15th Sep 20089:21 amRNSEPT Disclosure
12th Sep 20089:49 amRNSEPT Disclosure - Replacement
12th Sep 20089:10 amRNSEPT Disclosure - Correction
12th Sep 20088:53 amRNSEPT Disclosure
11th Sep 20085:40 pmBUSRule 8.3 - Flying Brands
3rd Sep 20088:35 amRNSEPT Disclosure
2nd Sep 20088:54 amRNSEPT Disclosure
28th Aug 200810:07 amRNSEPT Disclosure
27th Aug 20083:17 pmBUSRule 8.3 - Flying Brands
27th Aug 20089:28 amRNSEPT Disclosure
26th Aug 200811:04 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.